Teva Pharmaceutical Industries Ltd (TEVA)
NYSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.79B | 3.59B | 3.88B | 3.66B | 3.88B | 3.85B | 4.46B | 3.82B |
| Operating Income | -950M | 419M | -874M | 2M | -646M | 355M | 697M | -216M |
| Pre Tax Income | -1.16B | 166M | -1.1B | -258M | -914M | 75M | 473M | -467M |
| Net Income | -232M | 55M | -1.22B | -205M | -863M | 80M | 429M | -139M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -950M | 419M | -856M | 2M | -646M | 355M | 722M | -217M |
| EBITDA | 217M | 768M | 877M | 494M | 428M | 686M | 1.03B | 735M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 21.9B | 22.39B | 18.85B | 16.89B | 16.66B | 15.88B | 14.93B | 15.85B |
| Operating Income | 2.15B | -17.48B | -1.65B | -443M | -3.58B | 1.71B | -2.12B | 408M |
| Pre Tax Income | 824M | -18.38B | -2.6B | -1.27B | -4.41B | 658M | -3.07B | -624M |
| Net Income | 68M | -16.53B | -2.4B | -999M | -3.99B | 417M | -2.35B | -559M |
| Preferred Dividends | -261M | -260M | -249M | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0.06 | -16.179 | -2.192 | -0.911 | -3.626 | 0.377 | -2.11 | -0.497 |
| EBIT | 2.15B | -17.48B | -1.7B | -440M | -3.57B | 1.72B | -2.1B | 433M |
| EBITDA | 5.29B | 5.47B | 5.71B | 3.06B | 4.52B | 3.62B | 1.64B | 2.64B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
